GlassScriptPhysician profile
Micheal Raad
NPI 1245735844
$2,701.06
in general payments reported to CMS, 2019-2025
10 companies · $2,068 in 2025
The $2,068 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $633 · 2025: $2,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,062 · Travel and Lodging: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,062.20 |
| Travel and Lodging | $638.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $751.86 | 2025 | |
| Stryker Corporation | $594.64 | 2024-2025 | Everest Spinal System, N/A |
| Providence Medical Technology, INC. | $289.88 | 2025 | |
| Si-Bone, INC. | $274.84 | 2024 | |
| Vb Spine LLC | $244.50 | 2025 | Everest Spinal System, Capri Corpectomy Cage System |
| Orthofix Medical, INC. | $140.02 | 2025 | 7d Surgical System |
| Globus Medical, INC. | $112.05 | 2025 | Excelsius Gps |
| Supreme Orthopedic Systems, LLC | $108.44 | 2024 | |
| Coloplast Corp | $92.61 | 2025 | |
| Medtronic, INC. | $92.22 | 2025 | Unid_pass |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micheal Raad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.